Patients receiving care in hospitals during surges have up to twice the COVID-19 mortality risk versus those seen in nonsurging hospital-months
COVID-19 Death Toll Passes 4 Million Globally
Rapid spread of the Delta variant has prompted the U.S. government to send a COVID-19 surge team to provide support in Southwest Missouri
Patient Engagement May Not Drive Return to In-Person Visits
Findings seen among patients receiving letter during reopening following cancellation of in-person care during COVID-19
Delta Variant Now Behind More Than 50 Percent of U.S. COVID-19 Cases
Alpha variant, which first surfaced in Britain and dominated infections in America for months, now only accounts for 28.7 percent of cases
Blood Shortages Causing Surgery Delays Across the United States
Some U.S. blood centers have only a one-day supply
Two-Dose Novavax Vaccine Protects Against SARS-CoV-2 Infection
Vaccine efficacy in adults was 89.7 percent overall, 86.3 percent against B.1.1.7 (alpha) variant, and 96.4 percent against non-B.1.1.7 variants
Teens’ Perceived Availability of Pot, Alcohol, Vaping Devices Down During Pandemic
Findings based on survey taken before, during COVID-19 pandemic, but actual use did not decline as dramatically
Just 20 States Reached Biden’s July 4 Vaccination Goal
Parts of the South, Southwest, and Midwest starting to see surges, particularly Florida, with about 17 percent of all new cases reported there
Britain to Fully Reopen Soon, Despite Rising COVID-19 Cases
Confirmed COVID-19 cases in Britain have increased, but number of deaths has stayed stable
Variable Antibody Response Found Following mRNA COVID-19 Vaccination
Multiple myeloma patients had a variable response to mRNA COVID-19 vaccines pointing to the need for antibody testing and precautions for these blood cancer patients after vaccination, according to a study published in Cancer Cell on June 29, 2021.
New York City-based Mount Sinai researchers found that multiple myeloma patients mount variable and sometimes suboptimal responses after receiving either the Pfizer-BioNTech or Moderna COVID-19 vaccines.